SYDNEY: Emerald Clinics Limited, a leader in the collection and clinical translation of Real-World Evidence technologies, has been engaged by Spectrum Biomedical UK (SBUK), the UK subsidiary of the world’s largest cannabis company Canopy Growth, to develop a Real-World Evidence system in the United Kingdom (UK). Under the agreement Emerald will design and deliver a…